Dark

NBIX
Neurocrine Biosciences Inc
stock NASDAQ

At Close

Aug 28, 2025 3:59:42 PM EDT

138.98USD+0.615%(+0.85)449,618

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-138.13)0

After-hours

Aug 28, 2025 4:03:30 PM EDT

138.94USD-0.029%(-0.04)14,598

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

13.78B

CEO

Kevin Gorman

Headquarters

San Diego, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Nov 4, 2025 (67d)

RGEN ATHX LLY PFE PTN ABBV ANIP CASI PRTK XLV

NBIX Stats

Avg. Vol. 10 Day

659,828

Avg. Vol. 30 Day

934,023

Employees

470

Market Cap

13,781,270,814

Shares Out.

99,181,510

On/Off Exchange

57%/43%

6 Month Beta

0.86

1 Year Beta

0.85

2 Year Beta

0.72

3 Year Beta

0.62

52 Week Low

84.23

52 Week High

154.61

SMA50

130.72

SMA200

124.36

1 Week

+2.71%

1 Month

+3.92%

3 Month

+12.94%

6 Month

+17.04%

1 Year

+12.27%

2 Year

+30.01%

5 Year

+21.55%

Profile

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

NBIX Stock Summary

Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $138.98, and today's volume is 449,618. NBIX is up 0.615% today. The 30 day average volume is 934,023. NBIX market cap is 13.78B with 99,181,510 shares outstanding.